Skip to main content
Deborah Grady, MD, Internal Medicine, San Francisco, CA

DeborahGradyMD

Internal Medicine San Francisco, CA

Professor, Medicine, UCSF School of Medicine

Are you Dr. Grady?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 56 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    4150 Clement St
    Mail Code 111a1
    San Francisco, CA 94121
    Phone+1 415-750-2093
    Fax+1 415-379-5573

Summary

  • Dr. Deborah Grady, MD is a board certified internist in San Francisco, California. She is currently licensed to practice medicine in California. She is affiliated with San Francisco VA Medical Center and UCSF Medical Center.

Education & Training

  • University of California (San Francisco)/University of California School of Public Health
    University of California (San Francisco)/University of California School of Public HealthResidency, Public Health and General Preventive Medicine, 1985 - 1987
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Internal Medicine, 1980 - 1983
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1980

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1982 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2009

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Specter of Suicidality with Antiobesity Med Looms Despite Disparate Study Findings
    Specter of Suicidality with Antiobesity Med Looms Despite Disparate Study FindingsSeptember 24th, 2024
  • ‘Reassuring’ Findings Suggest GLP-1 Receptor Agonists Do Not Increase Suicide Risk
    ‘Reassuring’ Findings Suggest GLP-1 Receptor Agonists Do Not Increase Suicide RiskSeptember 4th, 2024
  • New Studies Fuel Debate over GLP-1 Drugs and Suicide Risk
    New Studies Fuel Debate over GLP-1 Drugs and Suicide RiskSeptember 3rd, 2024
  • Join now to see all